Cor triatriatum medical therapy

Jump to navigation Jump to search

Cor triatriatum Microchapters

Home

Patient Info

Overview

Pathophysiology

Epidemiology & Demographics

Risk Factors

Natural History, Complications & Prognosis

Causes of Cor triatriatum

Differentiating Cor triatriatum from other Diseases

Diagnosis

History & Symptoms

Physical Examination

Electrocardiogram

Chest X Ray

MRI

CT

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cor triatriatum medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cor triatriatum medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cor triatriatum medical therapy

CDC on Cor triatriatum medical therapy

Cor triatriatum medical therapy in the news

Blogs on Cor triatriatum medical therapy

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Cor triatriatum medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]

Overview

In cor triatriatum, adminstration of effective medical therapy in a timely manner can serve as a supplementary, supportive measure prior to surgical therapy. Medical therapy measures should focus on addresses various complication complexes and preventing further complications from developing prior to surgery.

Medical therapy

Medical therapy is primarily supportive to manage pulmonary venous congestion until surgical resection can be performed.

Commonly, medical therapy includes:

  • Hemodynamic stabilization via manipulation of hypoxemia, pulmonary congestion and fluid overload
  • Use of anticoagulants and anticoagulant prophylaxis to serve as a preventative measure in right-sided heart failure patients prone to deep vein thrombosis and pulmonary embolization
  • Control and stablization of ventricular rate in patients with a support atrial fibrillation complex
  • Use of medication to control fluid retention and the rate-control of arrhythmias

References


Template:WikiDoc Sources